Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Matas

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 5, 2019
Belatacept-based immunosuppression with simultaneous calcineurin inhibitor avoidance and early corticosteroid withdrawal: A prospective, randomized multicenter trialE Steve Woodle, Dixon B Kaufman, Adele R Shields, et al.
Transplantation|June 26, 2007
Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipientsRita Alloway, Steven Steinberg, Kassem Khalil, et al.
Transplantation|April 5, 2017
Rapid Discontinuation of Prednisone in Kidney Transplant Recipients: 15-Year Outcomes From the University of MinnesotaOscar Kenneth Serrano, Raja Kandaswamy, Kristen Gillingham, et al.
Clinical Transplants|July 5, 2012
High immunologic risk living donor kidney transplant using bortezomib in a novel induction regimen without acute antibody mediated rejectionTy B Dunn, Daniel Borja-Cacho, Srinath Chinnakotla, et al.
Clinical Transplantation|October 15, 2025
Similarities and Differences Between Allogeneic Hematopoietic Cell and Organ Transplantation and What We Can Learn From Each Other to Guide Global Health StrategyHildegard T Greinix, Arthur Matas, Mickey B C Koh, et al.
Journal of the American Society of Nephrology : JASN|November 8, 2014
Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant RecipientsPhilip F Halloran, Jessica Chang, Konrad Famulski, et al.
Transplantation|May 30, 2006
The ethics statement of the Vancouver Forum on the live lung, liver, pancreas, and intestine donorTimothy L Pruett, Annika Tibell, Abdulmajeed Alabdulkareem, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2004
National conference to assess antibody-mediated rejection in solid organ transplantationSteven K Takemoto, Adriana Zeevi, Sandy Feng, et al.
Research Square|April 1, 2024
Extreme Phenotype Sampling and Next Generation Sequencing to Identify Genetic Variants Associated with Tacrolimus in African American Kidney Transplant RecipientsMoataz Mohamed, Bin Guo, Baolin Wu, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 23, 2009
Transplant tourism and unregulated black-market trafficking of organsThomas Starzl, Lewis Teperman, David Sutherland, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 5, 2019
Belatacept-based immunosuppression with simultaneous calcineurin inhibitor avoidance and early corticosteroid withdrawal: A prospective, randomized multicenter trialE Steve Woodle, Dixon B Kaufman, Adele R Shields, et al.
Transplantation|June 26, 2007
Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipientsRita Alloway, Steven Steinberg, Kassem Khalil, et al.
Transplantation|April 5, 2017
Rapid Discontinuation of Prednisone in Kidney Transplant Recipients: 15-Year Outcomes From the University of MinnesotaOscar Kenneth Serrano, Raja Kandaswamy, Kristen Gillingham, et al.
Clinical Transplants|July 5, 2012
High immunologic risk living donor kidney transplant using bortezomib in a novel induction regimen without acute antibody mediated rejectionTy B Dunn, Daniel Borja-Cacho, Srinath Chinnakotla, et al.
Clinical Transplantation|October 15, 2025
Similarities and Differences Between Allogeneic Hematopoietic Cell and Organ Transplantation and What We Can Learn From Each Other to Guide Global Health StrategyHildegard T Greinix, Arthur Matas, Mickey B C Koh, et al.
Journal of the American Society of Nephrology : JASN|November 8, 2014
Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant RecipientsPhilip F Halloran, Jessica Chang, Konrad Famulski, et al.
Transplantation|May 30, 2006
The ethics statement of the Vancouver Forum on the live lung, liver, pancreas, and intestine donorTimothy L Pruett, Annika Tibell, Abdulmajeed Alabdulkareem, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2004
National conference to assess antibody-mediated rejection in solid organ transplantationSteven K Takemoto, Adriana Zeevi, Sandy Feng, et al.
Research Square|April 1, 2024
Extreme Phenotype Sampling and Next Generation Sequencing to Identify Genetic Variants Associated with Tacrolimus in African American Kidney Transplant RecipientsMoataz Mohamed, Bin Guo, Baolin Wu, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 23, 2009
Transplant tourism and unregulated black-market trafficking of organsThomas Starzl, Lewis Teperman, David Sutherland, et al.
Pageof 6